Koshinski Asset Management
EDIT icon

Koshinski Asset Management’s Editas Medicine EDIT Stock Holding History

Koshinski Asset Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-400
Closed -$7.61K – 939
2022
Q1 		$7.61K Hold
400
– – ﹤0.01% 1684
2021
Q4 		$10.6K Buy
400
+100
+33% +$3.44K ﹤0.01% 1618
2021
Q3 		$12.3K Buy
+300
New +$16.4K ﹤0.01% 1600

Other funds holding EDIT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Koshinski Asset Management's EDIT Position: Q2 2022 in Review

Koshinski Asset Management sold out of Editas Medicine (EDIT) in Q2 2022, closing a stake of 400 shares — an estimated $7.61K sold.

Koshinski Asset Management first reported a position in EDIT in Q3 2021 and held it in 3 quarters. The position peaked at $12.3K in Q3 2021. 256 funds tracked by Wall St. Rank hold EDIT as of Q2 2022.

  • Koshinski Asset Management reported no remaining Editas Medicine position as of Q2 2022 after selling out during the quarter.
  • Koshinski Asset Management sold 400 Editas Medicine shares in Q2 2022, an estimated $7.61K.
  • Koshinski Asset Management first reported a position in Editas Medicine in Q3 2021 and held it in 3 quarters.
  • Koshinski Asset Management's Editas Medicine position peaked at $12.3K in Q3 2021.
  • 256 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2022.

Based on Koshinski Asset Management's 13F filing for Q2 2022, filed 12 Jul 2022.